Evaluation of the dosimetric impact of non-exclusion of the rectum from the boost PTV in IMRT treatment plans for prostate cancer patients
To access this article, please choose from the options below
PII: S0167-8140(09)00051-6
doi:10.1016/j.radonc.2009.02.004
© 2009 Elsevier Ireland Ltd. All rights reserved.
